Concepts (239)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Face | 7 | 2021 | 21 | 3.120 |
Why?
|
| Facial Paralysis | 6 | 2021 | 9 | 2.890 |
Why?
|
| Free Tissue Flaps | 7 | 2020 | 12 | 2.640 |
Why?
|
| Surgery, Plastic | 4 | 2020 | 11 | 2.600 |
Why?
|
| Head and Neck Neoplasms | 7 | 2021 | 125 | 1.960 |
Why?
|
| Nerve Transfer | 3 | 2021 | 4 | 1.790 |
Why?
|
| Rhinoplasty | 4 | 2022 | 14 | 1.660 |
Why?
|
| Laryngectomy | 4 | 2020 | 12 | 1.520 |
Why?
|
| Search Engine | 2 | 2021 | 6 | 1.430 |
Why?
|
| Skin Neoplasms | 8 | 2021 | 67 | 1.410 |
Why?
|
| Nose | 2 | 2020 | 31 | 1.290 |
Why?
|
| Humans | 47 | 2022 | 22592 | 1.150 |
Why?
|
| Betacoronavirus | 4 | 2020 | 66 | 1.080 |
Why?
|
| Quality of Life | 3 | 2020 | 557 | 1.050 |
Why?
|
| Esthetics | 4 | 2020 | 11 | 1.040 |
Why?
|
| Coronavirus Infections | 4 | 2020 | 76 | 1.030 |
Why?
|
| Pneumonia, Viral | 4 | 2020 | 79 | 1.030 |
Why?
|
| Evidence-Based Medicine | 4 | 2021 | 135 | 0.990 |
Why?
|
| Surgical Flaps | 4 | 2014 | 49 | 0.920 |
Why?
|
| Carcinoma | 2 | 2018 | 67 | 0.890 |
Why?
|
| Internet | 2 | 2022 | 78 | 0.860 |
Why?
|
| Hypoglossal Nerve | 2 | 2021 | 4 | 0.860 |
Why?
|
| Retrospective Studies | 19 | 2020 | 2954 | 0.850 |
Why?
|
| Pharyngectomy | 2 | 2013 | 2 | 0.830 |
Why?
|
| Photography | 2 | 2020 | 9 | 0.810 |
Why?
|
| Clinical Laboratory Techniques | 2 | 2020 | 25 | 0.810 |
Why?
|
| Female | 26 | 2022 | 12734 | 0.780 |
Why?
|
| Skin | 2 | 2020 | 119 | 0.770 |
Why?
|
| Narcotics | 2 | 2020 | 32 | 0.770 |
Why?
|
| Laryngeal Neoplasms | 2 | 2020 | 23 | 0.770 |
Why?
|
| Analgesia | 2 | 2020 | 32 | 0.760 |
Why?
|
| Nasal Cartilages | 1 | 2022 | 3 | 0.760 |
Why?
|
| Middle Aged | 23 | 2020 | 7800 | 0.740 |
Why?
|
| Information Seeking Behavior | 1 | 2021 | 4 | 0.730 |
Why?
|
| Education, Distance | 1 | 2022 | 15 | 0.730 |
Why?
|
| Facial Nerve | 3 | 2019 | 7 | 0.720 |
Why?
|
| Mandibular Nerve | 1 | 2021 | 4 | 0.700 |
Why?
|
| Blepharoplasty | 1 | 2021 | 2 | 0.700 |
Why?
|
| Cosmetic Techniques | 1 | 2021 | 4 | 0.700 |
Why?
|
| Male | 25 | 2021 | 12260 | 0.680 |
Why?
|
| Beauty | 1 | 2020 | 2 | 0.670 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 2020 | 2 | 0.670 |
Why?
|
| Cephalometry | 1 | 2020 | 3 | 0.670 |
Why?
|
| Pharynx | 1 | 2020 | 10 | 0.660 |
Why?
|
| Patients | 1 | 2020 | 31 | 0.660 |
Why?
|
| Forehead | 1 | 2020 | 2 | 0.650 |
Why?
|
| Patient Preference | 1 | 2020 | 32 | 0.650 |
Why?
|
| Pain, Postoperative | 2 | 2020 | 269 | 0.630 |
Why?
|
| Trachea | 1 | 2020 | 37 | 0.630 |
Why?
|
| Biomedical Research | 1 | 2020 | 51 | 0.630 |
Why?
|
| Sex Characteristics | 1 | 2020 | 85 | 0.620 |
Why?
|
| Social Media | 1 | 2020 | 45 | 0.620 |
Why?
|
| Nose Neoplasms | 3 | 2014 | 33 | 0.620 |
Why?
|
| Health Behavior | 1 | 2020 | 136 | 0.610 |
Why?
|
| Sweat Gland Neoplasms | 1 | 2018 | 2 | 0.590 |
Why?
|
| Aged | 19 | 2021 | 7300 | 0.580 |
Why?
|
| Tissue and Organ Harvesting | 2 | 2015 | 14 | 0.560 |
Why?
|
| Thigh | 6 | 2015 | 26 | 0.540 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2020 | 574 | 0.540 |
Why?
|
| Carcinoma, Squamous Cell | 5 | 2021 | 153 | 0.540 |
Why?
|
| Neurosurgical Procedures | 1 | 2018 | 114 | 0.540 |
Why?
|
| Dermatologic Surgical Procedures | 3 | 2021 | 10 | 0.530 |
Why?
|
| Adult | 12 | 2020 | 6826 | 0.510 |
Why?
|
| Preoperative Care | 2 | 2020 | 104 | 0.510 |
Why?
|
| Cohort Studies | 8 | 2020 | 1386 | 0.510 |
Why?
|
| Mohs Surgery | 3 | 2013 | 3 | 0.470 |
Why?
|
| Carcinoma, Basal Cell | 3 | 2013 | 6 | 0.470 |
Why?
|
| Microcirculation | 1 | 2015 | 25 | 0.460 |
Why?
|
| Microvessels | 1 | 2015 | 12 | 0.450 |
Why?
|
| Perforator Flap | 1 | 2014 | 2 | 0.450 |
Why?
|
| Mouth Mucosa | 1 | 2014 | 10 | 0.450 |
Why?
|
| Nasal Mucosa | 1 | 2014 | 13 | 0.450 |
Why?
|
| Mouth Neoplasms | 1 | 2014 | 20 | 0.450 |
Why?
|
| Graft Survival | 5 | 2015 | 84 | 0.440 |
Why?
|
| Treatment Outcome | 8 | 2021 | 2915 | 0.430 |
Why?
|
| Monitoring, Physiologic | 2 | 2014 | 64 | 0.420 |
Why?
|
| Voice Quality | 1 | 2013 | 5 | 0.420 |
Why?
|
| Peripheral Nerves | 1 | 2012 | 15 | 0.380 |
Why?
|
| Postoperative Complications | 3 | 2014 | 804 | 0.380 |
Why?
|
| Muscle, Skeletal | 1 | 2015 | 323 | 0.380 |
Why?
|
| Tendon Transfer | 1 | 2012 | 15 | 0.370 |
Why?
|
| Parotid Gland | 1 | 2012 | 14 | 0.370 |
Why?
|
| Adenoidectomy | 1 | 2011 | 1 | 0.370 |
Why?
|
| Tonsillectomy | 1 | 2011 | 2 | 0.370 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2011 | 52 | 0.350 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2021 | 195 | 0.350 |
Why?
|
| Maxillary Sinus Neoplasms | 1 | 2010 | 7 | 0.340 |
Why?
|
| Head | 2 | 2022 | 16 | 0.340 |
Why?
|
| Drug Utilization | 2 | 2020 | 18 | 0.320 |
Why?
|
| Microsurgery | 3 | 2015 | 39 | 0.320 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 2010 | 58 | 0.320 |
Why?
|
| Endoscopy | 1 | 2010 | 165 | 0.310 |
Why?
|
| Wound Healing | 3 | 2015 | 108 | 0.300 |
Why?
|
| Risk Assessment | 4 | 2019 | 537 | 0.300 |
Why?
|
| Cardiovascular Diseases | 1 | 2011 | 281 | 0.290 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 2 | 2021 | 27 | 0.280 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 800 | 0.280 |
Why?
|
| Patient Care Planning | 2 | 2020 | 32 | 0.270 |
Why?
|
| Aged, 80 and over | 6 | 2015 | 3657 | 0.270 |
Why?
|
| Logistic Models | 2 | 2022 | 350 | 0.260 |
Why?
|
| Pandemics | 4 | 2020 | 198 | 0.260 |
Why?
|
| Comorbidity | 2 | 2020 | 423 | 0.230 |
Why?
|
| Neoplasm Invasiveness | 3 | 2021 | 84 | 0.220 |
Why?
|
| Neoplasm Staging | 2 | 2018 | 344 | 0.210 |
Why?
|
| Graft Rejection | 2 | 2015 | 61 | 0.210 |
Why?
|
| Otolaryngology | 2 | 2020 | 22 | 0.200 |
Why?
|
| Facial Nerve Injuries | 2 | 2012 | 2 | 0.190 |
Why?
|
| Chemoradiotherapy | 2 | 2014 | 54 | 0.190 |
Why?
|
| Young Adult | 3 | 2020 | 1607 | 0.190 |
Why?
|
| Nasal Septum | 1 | 2022 | 10 | 0.190 |
Why?
|
| SEER Program | 2 | 2019 | 32 | 0.190 |
Why?
|
| Reading | 1 | 2022 | 23 | 0.180 |
Why?
|
| Comprehension | 1 | 2022 | 24 | 0.180 |
Why?
|
| Survival Rate | 2 | 2019 | 302 | 0.170 |
Why?
|
| Gloves, Surgical | 1 | 2021 | 6 | 0.170 |
Why?
|
| Neoplasm Seeding | 1 | 2021 | 8 | 0.170 |
Why?
|
| Surgical Instruments | 1 | 2021 | 23 | 0.170 |
Why?
|
| Follow-Up Studies | 3 | 2014 | 1403 | 0.170 |
Why?
|
| Pain Measurement | 2 | 2020 | 411 | 0.170 |
Why?
|
| Hemostatic Techniques | 1 | 2020 | 6 | 0.170 |
Why?
|
| Prescriptions | 1 | 2020 | 15 | 0.170 |
Why?
|
| Epistaxis | 1 | 2020 | 9 | 0.170 |
Why?
|
| Rejuvenation | 1 | 2020 | 2 | 0.170 |
Why?
|
| Otorhinolaryngologic Diseases | 1 | 2020 | 5 | 0.170 |
Why?
|
| RNA, Viral | 1 | 2020 | 42 | 0.170 |
Why?
|
| Urban Health Services | 1 | 2020 | 11 | 0.160 |
Why?
|
| Tracheostomy | 1 | 2020 | 19 | 0.160 |
Why?
|
| Airway Management | 1 | 2020 | 15 | 0.160 |
Why?
|
| Biometry | 1 | 2020 | 5 | 0.160 |
Why?
|
| Feminization | 1 | 2020 | 2 | 0.160 |
Why?
|
| Physician-Patient Relations | 1 | 2020 | 36 | 0.160 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2020 | 21 | 0.160 |
Why?
|
| Point-of-Care Testing | 1 | 2020 | 26 | 0.160 |
Why?
|
| Robotic Surgical Procedures | 1 | 2020 | 23 | 0.160 |
Why?
|
| Motivation | 1 | 2020 | 80 | 0.160 |
Why?
|
| Simulation Training | 1 | 2020 | 33 | 0.160 |
Why?
|
| Tongue Neoplasms | 1 | 2019 | 15 | 0.160 |
Why?
|
| Masseter Muscle | 1 | 2019 | 2 | 0.160 |
Why?
|
| Neoplasm Grading | 1 | 2019 | 47 | 0.160 |
Why?
|
| Disease Management | 1 | 2020 | 99 | 0.150 |
Why?
|
| Human papillomavirus 16 | 1 | 2019 | 5 | 0.150 |
Why?
|
| Neck | 1 | 2019 | 21 | 0.150 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2015 | 289 | 0.150 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2019 | 15 | 0.150 |
Why?
|
| Tertiary Care Centers | 2 | 2020 | 63 | 0.150 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2019 | 62 | 0.150 |
Why?
|
| Morphine | 1 | 2019 | 69 | 0.150 |
Why?
|
| Cranial Nerve Neoplasms | 1 | 2018 | 2 | 0.150 |
Why?
|
| Facial Nerve Diseases | 1 | 2018 | 3 | 0.150 |
Why?
|
| Neoplasms, Unknown Primary | 1 | 2018 | 4 | 0.150 |
Why?
|
| Adenocarcinoma | 1 | 2019 | 130 | 0.150 |
Why?
|
| Telemedicine | 1 | 2020 | 84 | 0.150 |
Why?
|
| Sarcoma | 1 | 2021 | 140 | 0.140 |
Why?
|
| Morbidity | 2 | 2015 | 49 | 0.140 |
Why?
|
| Clinical Competence | 1 | 2020 | 190 | 0.140 |
Why?
|
| Prognosis | 3 | 2019 | 719 | 0.140 |
Why?
|
| Patient Satisfaction | 1 | 2020 | 255 | 0.140 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 752 | 0.130 |
Why?
|
| Length of Stay | 1 | 2019 | 293 | 0.130 |
Why?
|
| Forearm | 2 | 2015 | 17 | 0.130 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2020 | 311 | 0.130 |
Why?
|
| Analgesics, Opioid | 1 | 2019 | 209 | 0.130 |
Why?
|
| Age Factors | 1 | 2018 | 623 | 0.130 |
Why?
|
| United States | 2 | 2019 | 1741 | 0.130 |
Why?
|
| Adolescent | 2 | 2011 | 1855 | 0.120 |
Why?
|
| Multivariate Analysis | 2 | 2019 | 282 | 0.120 |
Why?
|
| Disease-Free Survival | 2 | 2019 | 168 | 0.120 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2019 | 165 | 0.120 |
Why?
|
| Databases, Factual | 2 | 2019 | 300 | 0.120 |
Why?
|
| Combined Modality Therapy | 2 | 2019 | 292 | 0.120 |
Why?
|
| Practice Guidelines as Topic | 3 | 2021 | 228 | 0.120 |
Why?
|
| Smiling | 1 | 2015 | 2 | 0.120 |
Why?
|
| Interdisciplinary Communication | 2 | 2013 | 16 | 0.120 |
Why?
|
| Cooperative Behavior | 2 | 2013 | 48 | 0.110 |
Why?
|
| Anastomosis, Surgical | 1 | 2015 | 27 | 0.110 |
Why?
|
| Rhabdomyosarcoma, Embryonal | 1 | 2014 | 3 | 0.110 |
Why?
|
| Wounds and Injuries | 1 | 2015 | 34 | 0.110 |
Why?
|
| Biopsy, Needle | 2 | 2014 | 101 | 0.110 |
Why?
|
| Recovery of Function | 2 | 2012 | 241 | 0.110 |
Why?
|
| Reoperation | 2 | 2014 | 742 | 0.110 |
Why?
|
| Immunohistochemistry | 2 | 2014 | 333 | 0.110 |
Why?
|
| Patient Readmission | 1 | 2015 | 117 | 0.110 |
Why?
|
| Patient Discharge | 1 | 2015 | 146 | 0.100 |
Why?
|
| Hypopharynx | 1 | 2013 | 1 | 0.100 |
Why?
|
| Surgical Stomas | 1 | 2013 | 2 | 0.100 |
Why?
|
| Tracheotomy | 1 | 2013 | 3 | 0.100 |
Why?
|
| Nose Deformities, Acquired | 1 | 2013 | 1 | 0.100 |
Why?
|
| Postoperative Care | 1 | 2013 | 107 | 0.100 |
Why?
|
| Academic Medical Centers | 1 | 2013 | 120 | 0.100 |
Why?
|
| Temporal Muscle | 1 | 2012 | 1 | 0.090 |
Why?
|
| Dexamethasone | 1 | 2012 | 34 | 0.090 |
Why?
|
| Parotid Neoplasms | 1 | 2012 | 11 | 0.090 |
Why?
|
| Glucocorticoids | 1 | 2012 | 58 | 0.090 |
Why?
|
| Quadriceps Muscle | 1 | 2012 | 25 | 0.090 |
Why?
|
| Polysomnography | 1 | 2011 | 72 | 0.090 |
Why?
|
| Echocardiography | 1 | 2011 | 60 | 0.090 |
Why?
|
| Cadaver | 1 | 2012 | 274 | 0.090 |
Why?
|
| Unnecessary Procedures | 1 | 2011 | 25 | 0.090 |
Why?
|
| Electrocardiography | 1 | 2011 | 89 | 0.090 |
Why?
|
| Confidence Intervals | 1 | 2010 | 75 | 0.080 |
Why?
|
| Patient Care Team | 1 | 2011 | 110 | 0.080 |
Why?
|
| Survival Analysis | 1 | 2010 | 227 | 0.080 |
Why?
|
| Infant | 1 | 2011 | 478 | 0.080 |
Why?
|
| Child, Preschool | 1 | 2011 | 561 | 0.080 |
Why?
|
| Child | 1 | 2011 | 1148 | 0.070 |
Why?
|
| Risk Factors | 1 | 2011 | 1955 | 0.060 |
Why?
|
| Cytological Techniques | 1 | 2021 | 13 | 0.040 |
Why?
|
| Salvage Therapy | 1 | 2021 | 29 | 0.040 |
Why?
|
| Margins of Excision | 1 | 2021 | 27 | 0.040 |
Why?
|
| Disease Transmission, Infectious | 1 | 2020 | 18 | 0.040 |
Why?
|
| Clinical Protocols | 1 | 2020 | 52 | 0.040 |
Why?
|
| Emergencies | 1 | 2020 | 27 | 0.040 |
Why?
|
| Tongue | 1 | 2019 | 6 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2021 | 369 | 0.040 |
Why?
|
| Genetic Heterogeneity | 1 | 2019 | 8 | 0.040 |
Why?
|
| Patient Selection | 1 | 2020 | 167 | 0.040 |
Why?
|
| Clinical Decision-Making | 1 | 2019 | 40 | 0.040 |
Why?
|
| Reference Values | 1 | 2019 | 159 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2019 | 269 | 0.040 |
Why?
|
| Mass Screening | 1 | 2020 | 152 | 0.040 |
Why?
|
| Chicago | 1 | 2020 | 788 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2021 | 1476 | 0.030 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2015 | 7 | 0.030 |
Why?
|
| Ohio | 1 | 2015 | 4 | 0.030 |
Why?
|
| Treatment Refusal | 1 | 2014 | 10 | 0.030 |
Why?
|
| Laryngoscopy | 1 | 2014 | 17 | 0.030 |
Why?
|
| Rare Diseases | 1 | 2014 | 12 | 0.030 |
Why?
|
| Hospitals | 1 | 2015 | 155 | 0.030 |
Why?
|
| Quality of Health Care | 1 | 2015 | 90 | 0.030 |
Why?
|
| Fascia Lata | 1 | 2013 | 6 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2012 | 54 | 0.020 |
Why?
|
| Melanoma | 1 | 2013 | 49 | 0.020 |
Why?
|
| Cartilage | 1 | 2013 | 70 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2013 | 126 | 0.020 |
Why?
|
| Bone Transplantation | 1 | 2013 | 153 | 0.020 |
Why?
|
| Time Factors | 1 | 2014 | 1247 | 0.020 |
Why?
|
| Rats | 1 | 2012 | 625 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2012 | 512 | 0.020 |
Why?
|
| Animals | 1 | 2012 | 3238 | 0.010 |
Why?
|